NPCE compared with NVCR: revenue, margins and what each company keeps, and the suppliers and customers both name

NPCENeuroPace Inc

Mkt capRevenueRevenue

NVCRNovoCure Ltd

Mkt capRevenueRevenue

Compare

NPCENeuroPace Inc

NVCRNovoCure Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NPCE 4

—DIXI Medical USAunlistedsupplier

GBCIGreatbatchsupplier

—Micro Systems Technologies Managementunlistedsupplier

—Rapport Therapeuticsunlistedcustomer

Shared 0

No shared counterparties.

Only NVCR 3

ZLABZai Labcustomer

—Zai Lab (Shanghai)unlistedcustomer

—Zaiunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

NPCENeuroPace Inc

12.63· pre 12.85· delayed

Mkt cap$435.6MRevenue$23MQ2 FY26Revenue$96MFY25

NVCRNovoCure Ltd

13.53· pre 13.54· delayed

Pre-marketNov 5 '26delayed

Mkt cap$1.7BRevenue$193MQ3 FY26Revenue$655MFY25

Compare

Pre-marketNov 5 '26delayed

NPCENeuroPace Inc

NVCRNovoCure Ltd

12.63pre 12.85delayed

Price

13.53pre 13.54delayed

$435.6M

Mkt cap

$1.7B

Q2 FY26$23M

Revenue

$193MQ3 FY26

FY25$96M

Revenue

$655MFY25

NPCE12.63vsNVCR13.53Pre-marketNov 5 '26delayed